This product is for research use only, not for human use. We do not sell to patients.
Size | Price | Stock |
---|---|---|
100mg | $1300 | Check With Us |
250mg | $2100 | Check With Us |
500mg | $3150 | Check With Us |
Cat #: V1014 CAS #: 1269440-17-6 Purity ≥ 98%
Description: Encorafenib (formerly LGX818; LGX-818; trade name Braftovi), an approved anticancer drug, is a highly potent, and orally bioavailable B-RAFV600E inhibitor with potential antineoplastic activity.
References: Compounds and compositions as protein kinase inhibitors . Patent WO 2011025927 A1
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
Molecular Weight (MW) | 540.01 |
---|---|
Molecular Formula | C22H27ClFN7O4S |
CAS No. | 1269440-17-6 |
Storage | -20℃ for 3 years in powder formr |
-80℃ for 2 years in solvent | |
Solubility In Vitro | DMSO: 100 mg/mL (185.2 mM)r |
Water: <1 mg/mLr | |
Ethanol: 100 mg/mL (185.2 mM) | |
SMILES Code | O=C(OC)N[C@@H](C)CNC1=NC=CC(C2=CN(C(C)C)N=C2C3=CC(Cl)=CC(NS(=O)(C)=O)=C3F)=N1 |
Synonyms | LGX-818; Encorafenib; LGX818; LGX 818 |
Protocol | In Vitro | Encorafenib (LGX818) is a potent drug that can prevents diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of B-Raf. |
---|
Solvent volume to be added | Mass (the weight of a compound) | |||
---|---|---|---|---|
Mother liquor concentration | 1mg | 5mg | 10mg | 20mg |
1mM | 1.8518 mL | 9.2591 mL | 18.5182 mL | 37.0364 mL |
5mM | 0.3704 mL | 1.8518 mL | 3.7036 mL | 7.4073 mL |
10mM | 0.1852 mL | 0.9259 mL | 1.8518 mL | 3.7036 mL |
20mM | 0.0926 mL | 0.4630 mL | 0.9259 mL | 1.8518 mL |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.